ISBA 2010 World Meeting

ISBA 2010 世界会议

• 批准号: 7913675
• 负责人: PETER MUELLER
• 金额: $ 0.5万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-14 至 2011-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7913675
• 关键词: Address; Area; Bayesian Analysis; Bayesian Method; Bioinformatics; Biomedical Research; Biometry; Clinical Data; Clinical Research; Clinical Trials Design; Collaborations; Communities; Data; Development; Ethics; Event; Fertilization; Goals; Government; Grant; Individual; Industry; International; Methods; Mission; Pathway interactions; Patients; Qualifying; Research; Research Personnel; Science; Societies; Solutions; Spain; Travel; Underrepresented Minority; Woman; Work; anticancer research; interest; meetings; novel strategies; programs; protein expression; public health relevance; statistics; symposium; theories

DESCRIPTION (provided by applicant): The ISBA 2010 World Meeting (http://www.bayesian.org/events/isba2010/) will be held in Benidorm, Spain, June 3-8, 2010. The conference will be held in conjunction with the Ninth Valencia International Meeting on Bayesian Statistics. The International Society for Bayesian Analysis (ISBA, www.bayesian.org) was established in 1992. Its mission is to promote the development and application of Bayesian statistical theory and methods useful in the solution of theoretical and applied problems in science, industry and government. Its mission is to promote the development and application of Bayesian statistical theory and methods useful in the solution of theoretical and applied problems in science, industry and government. Over the last 10 years Bayesian methods have been increasingly used in inference for biomedical research problems. By sponsoring and organizing meetings and other activities ISBA provides a focal point for those interested in Bayesian inference and its applications. In general terms, the purpose of the conference is to bring together the diverse international community of investigators in statistics and in other areas who develop and use Bayesian methods to share recent findings and to present new and challenging problems to be addressed by the community. Meeting organizers hope to provide a venue that facilitates the exchange of ideas and cross-fertilization, is welcoming to young researchers, and promotes collaborations and interactions. All of the requested grant will go towards travel expenses of new researchers who present work related to cancer research. At least 50% will support women and underrepresented minorities. The meeting will be organized to actively encourage participation of new researchers and underrepresented groups, and to provide opportunities for the initiation of international collaborations. We will achieve this goal by identifying and inviting appropriate qualified individuals, and by a variety of activities in the planned conference program. PUBLIC HEALTH RELEVANCE: The conference is expected to significantly advance research in Bayesian biostatistics and bioinformatics and thereby help patients get faster access to better and more personalized treatment options. For example, novel approaches in Bayesian clinical trial design respond to the need for increased efficiency and ethical standards in clinical studies. Integrating protein expression data, pathway information and clinical data is critical to allow patients and clinicians to select the most promising treatment options for specific patients.

描述（由申请人提供）：ISBA 2010世界会议（http：//www.bayesian.org/events/isba2010/）将于2010年6月3日至8日在西班牙贝尼多姆举行。会议将与第九届瓦伦西亚贝叶斯统计国际会议同时举行。 国际贝叶斯分析学会（ISBA，www.bayesian.org）成立于1992年。它的使命是促进贝叶斯统计理论和方法的发展和应用，有助于解决科学，工业和政府的理论和应用问题。它的使命是促进贝叶斯统计理论和方法的发展和应用，有助于解决科学，工业和政府的理论和应用问题。在过去的10年中，贝叶斯方法越来越多地用于生物医学研究问题的推理。通过赞助和组织会议和其他活动，国际贝叶斯律师协会为那些对贝叶斯推理及其应用感兴趣的人提供了一个联络点。 总的来说，会议的目的是汇集统计和其他领域的研究人员的不同国际社会谁开发和使用贝叶斯方法，分享最新的研究结果，并提出新的和具有挑战性的问题，由社区解决。会议组织者希望提供一个场所，促进思想交流和交叉施肥，欢迎年轻的研究人员，并促进合作和互动。 所有申请的补助金将用于新研究人员的差旅费，这些研究人员目前正在进行与癌症研究有关的工作。至少50%的人将支持妇女和代表性不足的少数民族。会议的组织将积极鼓励新的研究人员和代表性不足的群体参加，并为开展国际合作提供机会。我们将通过确定和邀请合适的合格人员以及计划会议计划中的各种活动来实现这一目标。 公共卫生相关性：该会议预计将大大推进贝叶斯生物统计学和生物信息学的研究，从而帮助患者更快地获得更好、更个性化的治疗方案。例如，贝叶斯临床试验设计中的新方法响应了临床研究中提高效率和道德标准的需求。整合蛋白质表达数据、途径信息和临床数据对于患者和临床医生为特定患者选择最有希望的治疗方案至关重要。